ABOS
Price
$1.21
Change
-$0.02 (-1.63%)
Updated
Jun 26 closing price
Capitalization
73.29M
52 days until earnings call
ATOS
Price
$0.88
Change
+$0.02 (+2.33%)
Updated
Jun 26 closing price
Capitalization
113.33M
52 days until earnings call
Interact to see
Advertisement

ABOS vs ATOS

Header iconABOS vs ATOS Comparison
Open Charts ABOS vs ATOSBanner chart's image
Acumen Pharmaceuticals
Price$1.21
Change-$0.02 (-1.63%)
Volume$215.3K
Capitalization73.29M
Atossa Therapeutics
Price$0.88
Change+$0.02 (+2.33%)
Volume$1.26M
Capitalization113.33M
ABOS vs ATOS Comparison Chart in %
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. ATOS commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a StrongBuy and ATOS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ABOS: $1.21 vs. ATOS: $0.88)
Brand notoriety: ABOS and ATOS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 89% vs. ATOS: 171%
Market capitalization -- ABOS: $73.29M vs. ATOS: $113.33M
ABOS [@Biotechnology] is valued at $73.29M. ATOS’s [@Biotechnology] market capitalization is $113.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileATOS’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • ATOS’s FA Score: 1 green, 4 red.
According to our system of comparison, ATOS is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 5 TA indicator(s) are bullish while ATOS’s TA Score has 4 bullish TA indicator(s).

  • ABOS’s TA Score: 5 bullish, 4 bearish.
  • ATOS’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both ABOS and ATOS are a good buy in the short-term.

Price Growth

ABOS (@Biotechnology) experienced а -0.82% price change this week, while ATOS (@Biotechnology) price change was +9.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 18, 2025.

ATOS is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATOS($113M) has a higher market cap than ABOS($73.3M). ATOS YTD gains are higher at: -7.065 vs. ABOS (-29.651). ATOS has higher annual earnings (EBITDA): -28.04M vs. ABOS (-111.98M). ABOS has more cash in the bank: 149M vs. ATOS (65.1M). ATOS has less debt than ABOS: ATOS (0) vs ABOS (29M). ABOS (0) and ATOS (0) have equivalent revenues.
ABOSATOSABOS / ATOS
Capitalization73.3M113M65%
EBITDA-111.98M-28.04M399%
Gain YTD-29.651-7.065420%
P/E RatioN/AN/A-
Revenue00-
Total Cash149M65.1M229%
Total Debt29M0-
FUNDAMENTALS RATINGS
ATOS: Fundamental Ratings
ATOS
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSATOS
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
69%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NINOY10.020.32
+3.25%
Nikon Corp.
KGSPY83.741.38
+1.68%
Kingspan Group plc.
AMADY80.450.31
+0.39%
Amadeus IT Group SA
GCMG11.48-0.03
-0.26%
GCM Grosvenor
ZURA1.15-0.03
-2.54%
Zura Bio Limited

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with FHTX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-1.63%
FHTX - ABOS
55%
Loosely correlated
-0.82%
CRBU - ABOS
53%
Loosely correlated
-4.93%
BEAM - ABOS
50%
Loosely correlated
+2.27%
CRSP - ABOS
49%
Loosely correlated
-0.17%
IPSC - ABOS
48%
Loosely correlated
+0.23%
More

ATOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATOS has been loosely correlated with ABOS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ATOS jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATOS
1D Price
Change %
ATOS100%
+1.81%
ABOS - ATOS
48%
Loosely correlated
-1.63%
IMNM - ATOS
44%
Loosely correlated
+1.27%
KALV - ATOS
44%
Loosely correlated
-1.54%
GBIO - ATOS
44%
Loosely correlated
-2.63%
MGNX - ATOS
43%
Loosely correlated
-3.05%
More